Serum Folate in Patients Treated with Olaparib
https://www.facingourrisk.org/research-clinical-trials/study/99/serum-folate-in-patients-treated-with-olaparib
Clinicaltrials.gov identifier:
NCT04024254 (https://clinicaltrials.gov/show/NCT04024254)
Study Contact Information:
For questions about the study, contact the study nurse Lois Winkelman at 312-942-2417 or by email.
About the Study
This is a study looking at folate deficiency (lack of folic acid in the blood) in patients who take the drug olaparib (Lynparza) to treat their advanced ovarian or breast cancer. The main goal of this study is to measure how often and when folate deficiency is most likely to occur; and to learn more about whether giving folic acid supplements (vitamins) will help delay or avoid deficiency in these patients. Folate deficiency can cause side effects and lead to reduction or stopping of treatment with olaparib. NOTE: This study is no longer enrolling people.
This Study is Open To:
NOTE: This study is no longer enrolling people.
This Study is Not Open To:
NOTE: This study is no longer enrolling people.
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.